BRAF and melanoma: Based on these, selective inhibition of BRAF has been shown to induce an activated CD8+ T cell infiltrate, as well as increase melanoma MHC expression and melanoma antigen presentation early during treatment both in preclinical models and in human melanoma tissue samples (159–161).